A detailed history of Coastal Bridge Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Coastal Bridge Advisors, LLC holds 40,201 shares of PFE stock, worth $1.07 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
40,201
Previous 40,201 -0.0%
Holding current value
$1.07 Million
Previous $1.12 Million 0.81%
% of portfolio
0.32%
Previous 0.28%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $167,068 - $191,847
6,453 Added 19.12%
40,201 $1.12 Million
Q4 2023

Feb 15, 2024

BUY
$26.13 - $33.94 $21,139 - $27,457
809 Added 2.46%
33,748 $971,000
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $23,810 - $27,832
742 Added 2.3%
32,939 $1.09 Million
Q2 2023

Aug 16, 2023

SELL
$36.12 - $41.79 $104,603 - $121,023
-2,896 Reduced 8.25%
32,197 $1.18 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $18,434 - $23,999
-468 Reduced 1.32%
35,093 $1.43 Million
Q4 2022

Feb 08, 2023

SELL
$41.75 - $54.5 $70,307 - $91,778
-1,684 Reduced 4.52%
35,561 $1.82 Million
Q3 2022

Nov 15, 2022

BUY
$43.76 - $53.42 $100,560 - $122,759
2,298 Added 6.58%
37,245 $1.63 Million
Q2 2022

Nov 15, 2022

SELL
$46.53 - $55.17 $64,164 - $76,079
-1,379 Reduced 3.8%
34,947 $1.83 Million
Q2 2022

Aug 05, 2022

BUY
$46.53 - $55.17 $98,317 - $116,574
2,113 Added 6.18%
36,326 $1.91 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $1.37 Million - $1.69 Million
-29,844 Reduced 46.59%
34,213 $1.77 Million
Q4 2021

May 20, 2022

BUY
$41.32 - $61.25 $1.02 Million - $1.51 Million
24,663 Added 62.61%
64,057 $3.12 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $358,740 - $531,772
8,682 Added 28.27%
39,394 $2.33 Million
Q3 2021

May 20, 2022

SELL
$39.25 - $50.42 $221,370 - $284,368
-5,640 Reduced 15.51%
30,712 $1.32 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $225,962 - $290,267
5,757 Added 18.82%
36,352 $1.56 Million
Q2 2021

Aug 10, 2021

SELL
$35.91 - $40.68 $12,532 - $14,197
-349 Reduced 1.13%
30,595 $1.2 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $32,686 - $36,863
976 Added 3.26%
30,944 $1.12 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $153,359 - $195,009
-4,582 Reduced 13.26%
29,968 $1.1 Million
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $36,036 - $42,278
1,135 Added 3.4%
34,550 $1.27 Million
Q2 2020

Aug 11, 2020

BUY
$30.12 - $36.54 $9,216 - $11,181
306 Added 0.92%
33,415 $1.09 Million
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $3,838 - $5,484
142 Added 0.43%
33,109 $1.08 Million
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $526 - $597
-16 Reduced 0.05%
32,967 $1.29 Million
Q3 2019

Nov 08, 2019

BUY
$32.49 - $42.13 $8,739 - $11,332
269 Added 0.82%
32,983 $1.19 Million
Q2 2019

Aug 13, 2019

BUY
$36.98 - $41.52 $839,963 - $943,085
22,714 Added 227.14%
32,714 $1.42 Million
Q2 2019

Aug 07, 2019

SELL
$36.98 - $41.52 $834,379 - $936,815
-22,563 Reduced 69.29%
10,000 $1.42 Million
Q1 2019

May 08, 2019

BUY
$37.5 - $41.2 $4,012 - $4,408
107 Added 0.33%
32,563 $1.38 Million
Q4 2018

Feb 08, 2019

BUY
$38.47 - $43.86 $3,693 - $4,210
96 Added 0.3%
32,456 $1.42 Million
Q3 2018

Nov 08, 2018

BUY
$34.47 - $41.81 $101,893 - $123,590
2,956 Added 10.05%
32,360 $1.43 Million
Q2 2018

Aug 03, 2018

BUY
$32.98 - $35.16 $9,498 - $10,126
288 Added 0.99%
29,404 $1.07 Million
Q1 2018

May 11, 2018

BUY
$31.91 - $37.02 $77,126 - $89,477
2,417 Added 9.05%
29,116 $1.03 Million
Q4 2017

Feb 09, 2018

SELL
$33.26 - $35.29 $77,030 - $81,731
-2,316 Reduced 7.98%
26,699 $973,000
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $21,452 - $23,631
692 Added 2.44%
29,015 $1.04 Million
Q1 2017

Aug 14, 2017

BUY
N/A
28,323
28,323 $969,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Coastal Bridge Advisors, LLC Portfolio

Follow Coastal Bridge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Bridge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coastal Bridge Advisors, LLC with notifications on news.